Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma (Molecular Cancer, (2019), 18, 1, (141), 10.1186/s12943-019-1064-5)

Yan Xu, Yuan Li, Jiankang Jin, Guangchun Han, Chengcao Sun, Melissa Pool Pizzi, Longfei Huo, Ailing Scott, Ying Wang, Lang Ma, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, Christopher Vellano, Liuqing Yang, Chunru Lin, Youngsoo Kim, A. Robert MacLeod, Linghua Wang, Zhenning WangShumei Song, Jaffer A. Ajani

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], the authors identified minor errors in image-typesetting in Fig. 3; specifically the left hand side of Fig. 3d. The corrected figure is given below. The correction does not have any effect on the results or conclusions of the paper. (Figure presented.).

Original languageEnglish (US)
Article number56
JournalMolecular cancer
Volume20
Issue number1
DOIs
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma (Molecular Cancer, (2019), 18, 1, (141), 10.1186/s12943-019-1064-5)'. Together they form a unique fingerprint.

Cite this